News &
Notifications
All Categories
12 February 2021 | Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021
Ad hoc news
to the archive
Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit ...
February 12, 2021 | Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021
Corporate news
to the archive
Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to ...
KPS OFF TO A SOLID START IN THE NEW FINANCIAL YEAR 2020/2021
KPS continues with robust EBITDA in Q1 2020/2021; Group sales amounted to 36.3 million euros; EBITDA amounting to 5.3 million euros achieved
ESG: The role of ESG for private equity
In its latest study, Finance Magazin asked around 40 investment managers from medium-sized private equity houses about the role ESG plays in ...
KPS WITH COMPARATIVELY ROBUST RESULTS IN FINANCIAL YEAR 2019/2020
Business model and strategy have proved their resilience during the COVID-19 crisis. Group revenue at EUR 166.4m – 7.9% down on the previous FY. EBITDA of EUR 22.7m achieved (Partially comparable to previous FY owing to IFRS 16). Cash generation remains at a comparatively high level. Cost base reduced by EUR 10m.
ESG: The role of auditors
Corporate responsibility is becoming increasingly valued by the broader public. Companies try to live up to expectations by providing relevant ...
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
